FDA Clearance Tracker · K232013
Aperta NSE PTA Balloon Dilatation Catheter (AW18-05040040/AA18-05040040, AW18-09040040/AA18-09040040, AW18-14540040, AW18-05050040/AA18-05050040, AW18-09050040/AA18-09050040, AW18-14550040, AW18-05060040/AA18-05060040, AW18-09060040/AA18-09060040, AW18-14560040 AW18-05070040/AA18-05070040, AW18-09070040/AA18-09070040, AW18-14570040, AW18-05080040/AA18-05080040, AW18-09080040/AA18-09080040, AW18-14580040)
Last checked: Nov 19, 2026Latest source record: Mar 28, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Mar 28, 2024
Substantially Equivalent
Time to decision
266 days
Received Jul 6, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K232013
- Device name
- Aperta NSE PTA Balloon Dilatation Catheter (AW18-05040040/AA18-05040040, AW18-09040040/AA18-09040040, AW18-14540040, AW18-05050040/AA18-05050040, AW18-09050040/AA18-09050040, AW18-14550040, AW18-05060040/AA18-05060040, AW18-09060040/AA18-09060040, AW18-14560040 AW18-05070040/AA18-05070040, AW18-09070040/AA18-09070040, AW18-14570040, AW18-05080040/AA18-05080040, AW18-09080040/AA18-09080040, AW18-14580040)
- Applicant
- Goodman Co., Ltd.
- Applicant location
- Nagoya, JP
- Received
- Jul 6, 2023
- Decided
- Mar 28, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PNO. The earliest in FDA's data is K040155, decided Jul 1, 2004.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232013
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Goodman Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243944 · Decided Apr 22, 2025 · 123 days after receipt
Device type: Catheter, Percutaneous, Cutting/Scoring (PNO) · Cardiology
P230026 · Decided Jun 6, 2024 · 280 days after receipt
Device type: Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring (NWX) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.